USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Swedish Orphan Biovitrum AG

USPTO PatentsView assignee record - 21 granted patents across 13 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Swedish ranks #14,303 of 49,997 tracked US assignees by granted-patent volume, with 21 patents across 13 technology areas.

#14,303
of 49,997 US assignees by volume
Top 40%
by Innovation Score (38.6/100)
16.1
avg claims per patent
+13%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14303 · Foreign Corporation #14,303 · 21 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

  • GRANTS-SMALL 21 grants
  • MID-PACK #14,303/49,997
  • PHOTO-FINISH Sacks Holdings
  • CPC-FOCUS A61K · 13 areas
  • INNOV-THIN 38.6/100
  • CLAIMS-RICH 16.1 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-UP +13% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sacks Holdings, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Swedish’s 38.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Swedish

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Swedish's Innovation Score is 38.6/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Swedish?

Each dot is one of Swedish’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Swedish’s own 16.1 claims/patent is ABOVE the 12.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Swedish vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 20.920.92121.1 5101520 Granted patents (volume) Avg claims / patent Spinewelding AG - 21, 15.86SpineweldingSPS Technologies, LLC - 21, 14.05SPSSRG Global, LLC - 21, 16.52SRG GlobalSumco Techxiv Corporation - 21, 6.76Sumco TechxivSynergy Pharmaceuticals, Inc. - 21, 12.19Synergy Pharmaceu…Synztec Co., Ltd. - 21, 7SynztecSacks Holdings, Inc. - 21, 11.33Sacks HoldingsSam Carbis Asset Management, LLC - 21, 16.95Sam Carbis Asset…Swedish Orphan Biovitrum AG - 21, 16.05Swedish Orphan Bi…
Swedish vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Swedish's grants concentrate

Swedish Orphan Biovitrum AG is a focused PatentsView assignee: 13 CPC subclasses with 95.2% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2017. By volume, Swedish sits between Spinewelding AG and Sam Carbis Asset Management, LLC.

Swedish's three-year grant acceleration

Swedish Orphan Biovitrum AG shows 5 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Swedish's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Swedish holds 21 patents at rank #14,274, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Swedish

By rank, the assignees closest to #14,274 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Swedish's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Swedish, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Swedish ranks #1,122 of 7,163 assignees by patent count in that subclass.

Swedish's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 2015201720182019202020212022202320242025 4
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Swedish Orphan Biovitrum AG patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 14.3%
2017 1 4.8%
2018 2 9.5%
2019 2 9.5%
2020 1 4.8%
2021 3 14.3%
2022 2 9.5%
2023 2 9.5%
2024 1 4.8%
2025partial year 4 19.0%

Which technologies does Swedish Orphan Biovitrum AG patent most?

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Swedish Orphan Biovitrum AG's patent record in context - here's where to go next.

  • Swedish Orphan Biovitrum AG's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 95.2% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #14,303 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Swedish Orphan Biovitrum AG against Spinewelding AG, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 38.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.